메뉴 건너뛰기




Volumn 27, Issue 8, 2012, Pages 519-523

Radiotherapy for nasopharyngeal carcinoma and combined capecitabine and nimotuzumab treatment for lung metastases in a liver transplantation recipient: A case experience of sustained complete response

Author keywords

capecitabine; de novo tumor; intensity modulated radiotherapy; nasopharyngeal carcinoma; nimotuzumab; orthotopic liver transplantation

Indexed keywords

CAPECITABINE; NIMOTUZUMAB;

EID: 84867544481     PISSN: 10849785     EISSN: 15578852     Source Type: Journal    
DOI: 10.1089/cbr.2012.1206     Document Type: Article
Times cited : (13)

References (27)
  • 2
    • 0347596814 scopus 로고    scopus 로고
    • The expression of key cell cycle markers and presence of human papillomavirus in squamous cell carcinoma of the tonsil
    • Li W, Thompson CH, Cossart YE, et al. The expression of key cell cycle markers and presence of human papillomavirus in squamous cell carcinoma of the tonsil. Head Neck 2004;26:1.
    • (2004) Head Neck , vol.26 , pp. 1
    • Li, W.1    Thompson, C.H.2    Cossart, Y.E.3
  • 3
    • 70349256093 scopus 로고    scopus 로고
    • Cancer incidence and risk factors after solid organ transplantation
    • Vajdic CM, van Leeuwen MT. Cancer incidence and risk factors after solid organ transplantation. Int J Cancer 2009;125:1747.
    • (2009) Int J Cancer , vol.125 , pp. 1747
    • Vajdic, C.M.1    Van Leeuwen, M.T.2
  • 4
    • 0035177929 scopus 로고    scopus 로고
    • Risk factors for development of de novo neoplasia after liver transplantation
    • Xiol X, Guardiola J, Menendez S, et al. Risk factors for development of de novo neoplasia after liver transplantation. Liver Transpl 2001;7:971.
    • (2001) Liver Transpl , vol.7 , pp. 971
    • Xiol, X.1    Guardiola, J.2    Menendez, S.3
  • 6
    • 0030809592 scopus 로고    scopus 로고
    • De novo malignancies after liver transplantation using tacrolimus-based protocols or cyclosporine-based quadruple immunosuppression with an interleukin-2 receptor antibody or antithymocyte globulin
    • Jonas S, Rayes N, Neumann U, et al. De novo malignancies after liver transplantation using tacrolimus-based protocols or cyclosporine-based quadruple immunosuppression with an interleukin-2 receptor antibody or antithymocyte globulin. Cancer 1997;80:1141.
    • (1997) Cancer , vol.80 , pp. 1141
    • Jonas, S.1    Rayes, N.2    Neumann, U.3
  • 7
    • 57849169437 scopus 로고    scopus 로고
    • Risk of malignant neoplasms after liver transplantation: A population-based study
    • Aberg F, Pukkala E, Hockerstedt K, et al. Risk of malignant neoplasms after liver transplantation: A population-based study. Liver Transpl 2008;14:1428.
    • (2008) Liver Transpl , vol.14 , pp. 1428
    • Aberg, F.1    Pukkala, E.2    Hockerstedt, K.3
  • 8
    • 0042833184 scopus 로고    scopus 로고
    • De novo malignancies and liver transplantation
    • Rubio E, Moreno JM, Turrio'n VS, et al. De novo malignancies and liver transplantation. Transplant Proc 2003;35: 1896.
    • (2003) Transplant Proc , vol.35 , pp. 1896
    • Rubio, E.1    Moreno, J.M.2    Turrio'n, V.S.3
  • 9
    • 84859495333 scopus 로고    scopus 로고
    • De novo malignancies after liver transplantation: Incidence comparison with the korean cancer registry
    • Park HW, Hwang S, Ahn CS, et al. De novo malignancies after liver transplantation: Incidence comparison with the korean cancer registry. Transplant Proc 2012;44:802.
    • (2012) Transplant Proc , vol.44 , pp. 802
    • Park, H.W.1    Hwang, S.2    Ahn, C.S.3
  • 10
    • 0034883212 scopus 로고    scopus 로고
    • Tacrolimus and cyclosporine A inhibit allostimulatory capacity and cytokine production of human myeloid dendritic cells
    • Szabo G, Gavala C, Mandrekar P. Tacrolimus and cyclosporine A inhibit allostimulatory capacity and cytokine production of human myeloid dendritic cells. J Investig Med 2001;49:442.
    • (2001) J Investig Med , vol.49 , pp. 442
    • Szabo, G.1    Gavala, C.2    Mandrekar, P.3
  • 11
    • 0026722491 scopus 로고
    • Immunosuppressants FK506 and rapamycin function as reversal agents of the multidrug resistance phenotype
    • Arceci RJ, Stieglitz K, Bierer BE. Immunosuppressants FK506 and rapamycin function as reversal agents of the multidrug resistance phenotype. Blood 1992;80:1528.
    • (1992) Blood , vol.80 , pp. 1528
    • Arceci, R.J.1    Stieglitz, K.2    Bierer, B.E.3
  • 12
    • 77953286457 scopus 로고    scopus 로고
    • Phase II study of capecitabine as palliative treatment for patients with recurrent and metastatic squamous head and neck cancer after previous platinum-based treatment
    • Martinez-Trufero J, Isla D, Adansa JC, et al. Phase II study of capecitabine as palliative treatment for patients with recurrent and metastatic squamous head and neck cancer after previous platinum-based treatment. Br J Cancer 2010;102: 1687.
    • (2010) Br J Cancer , vol.102 , pp. 1687
    • Martinez-Trufero, J.1    Isla, D.2    Adansa, J.C.3
  • 13
    • 0036235128 scopus 로고    scopus 로고
    • First-line oral capecitabine therapy in metastatic colorectal cancer: A favorable safety profile compared with intravenous 5-fluorouracil/ leucovorin
    • Cassidy J, Twelves C, Van Cutsem E, et al. First-line oral capecitabine therapy in metastatic colorectal cancer: A favorable safety profile compared with intravenous 5-fluorouracil/ leucovorin. Ann Oncol 2002;13:566.
    • (2002) Ann Oncol , vol.13 , pp. 566
    • Cassidy, J.1    Twelves, C.2    Van Cutsem, E.3
  • 14
    • 0036174497 scopus 로고    scopus 로고
    • Incidence and severity of hand-foot syndrome in colorectal cancer patients treated with capecitabine: A single-institution experience
    • Abushullaih S, Saad ED, Munsell M, et al. Incidence and severity of hand-foot syndrome in colorectal cancer patients treated with capecitabine: A single-institution experience. Cancer Invest 2002;20:3.
    • (2002) Cancer Invest , vol.20 , pp. 3
    • Abushullaih, S.1    Saad, E.D.2    Munsell, M.3
  • 15
    • 4444335026 scopus 로고    scopus 로고
    • Hand-foot syndrome in patients treated with capecitabine-containing combination chemotherapy
    • Heo YS, Chang HM, Kim TW, et al. Hand-foot syndrome in patients treated with capecitabine-containing combination chemotherapy. J Clin Pharmacol 2004;44:1166.
    • (2004) J Clin Pharmacol , vol.44 , pp. 1166
    • Heo, Y.S.1    Chang, H.M.2    Kim, T.W.3
  • 16
    • 0035871538 scopus 로고    scopus 로고
    • Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: Results of a randomized phase III study
    • Hoff PM, Ansari R, Batist G, et al. Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: Results of a randomized phase III study. J Clin Oncol 2001;19:2282.
    • (2001) J Clin Oncol , vol.19 , pp. 2282
    • Hoff, P.M.1    Ansari, R.2    Batist, G.3
  • 17
    • 0035503151 scopus 로고    scopus 로고
    • Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: Results of a large phase III study
    • Van Cutsem E, Twelves C, Cassidy J, et al. Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: Results of a large phase III study. J Clin Oncol 2001;19:4097.
    • (2001) J Clin Oncol , vol.19 , pp. 4097
    • Van Cutsem, E.1    Twelves, C.2    Cassidy, J.3
  • 18
    • 84874107117 scopus 로고    scopus 로고
    • Advances in the management of recurrent or metastatic squamous cell carcinoma of the head and neck
    • Epub ahead of print]; DOI: 10.1002/hed.21910
    • Shin DM, Khuri FR. Advances in the management of recurrent or metastatic squamous cell carcinoma of the head and neck. Head Neck 2011[Epub ahead of print]; DOI: 10.1002/hed.21910.
    • (2011) Head Neck
    • Shin, D.M.1    Khuri, F.R.2
  • 19
    • 34250155320 scopus 로고    scopus 로고
    • Epidermal growth factor receptor copy number alterations correlate with poor clinical outcome in patients with head and neck squamous cancer
    • Temam S, Kawaguchi H, El-Naggar AK, et al. Epidermal growth factor receptor copy number alterations correlate with poor clinical outcome in patients with head and neck squamous cancer. J Clin Oncol 2007;25:2164.
    • (2007) J Clin Oncol , vol.25 , pp. 2164
    • Temam, S.1    Kawaguchi, H.2    El-Naggar, A.K.3
  • 20
    • 77953664765 scopus 로고    scopus 로고
    • Nimotuzumab,a promising therapeutic monoclonal for treatment of tumors of epithelial origin
    • Ramakrishnan MS, Eswaraiah A, Crombet T, et al. Nimotuzumab,a promising therapeutic monoclonal for treatment of tumors of epithelial origin. MAbs 2009;1:41.
    • (2009) MAbs , vol.1 , pp. 41
    • Ramakrishnan, M.S.1    Eswaraiah, A.2    Crombet, T.3
  • 21
    • 34247847993 scopus 로고    scopus 로고
    • Malignancies of the colorectum and anus in solid organ recipients
    • Aigner F, Boeckle E, Albright J, et al. Malignancies of the colorectum and anus in solid organ recipients. Transpl Int 2007;20:497.
    • (2007) Transpl Int , vol.20 , pp. 497
    • Aigner, F.1    Boeckle, E.2    Albright, J.3
  • 22
    • 4544226050 scopus 로고    scopus 로고
    • Prevalence of anal HPV infection in solid-organ transplant patients prior to immunosuppression
    • Roka S, Rasoul-Rockenschaub S, Roka J, et al. Prevalence of anal HPV infection in solid-organ transplant patients prior to immunosuppression. Transpl Int 2004;17:366.
    • (2004) Transpl Int , vol.17 , pp. 366
    • Roka, S.1    Rasoul-Rockenschaub, S.2    Roka, J.3
  • 24
    • 33846961801 scopus 로고    scopus 로고
    • Local administration of cidofovir for human papilloma virus associated skin lesions in transplant recipients
    • Bonatti H, Aigner F, De Clercq E, et al. Local administration of cidofovir for human papilloma virus associated skin lesions in transplant recipients. Transpl Int 2007; 20:238.
    • (2007) Transpl Int , vol.20 , pp. 238
    • Bonatti, H.1    Aigner, F.2    De Clercq, E.3
  • 25
    • 85047700479 scopus 로고    scopus 로고
    • Involvement of intact HPV16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control
    • Wiest T, Schwarz E, Enders C, et al. Involvement of intact HPV16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control. Oncogene 2002;21:1510.
    • (2002) Oncogene , vol.21 , pp. 1510
    • Wiest, T.1    Schwarz, E.2    Enders, C.3
  • 26
    • 77951457224 scopus 로고    scopus 로고
    • Comparison of human papillomavirus in situ hybridization and p16 immunohistochemistry in the detection of human papillomavirus-associated head and neck cancer based on a prospective clinical experience
    • Singhi AD, Westra WH. Comparison of human papillomavirus in situ hybridization and p16 immunohistochemistry in the detection of human papillomavirus-associated head and neck cancer based on a prospective clinical experience. Cancer 2010;116:2166.
    • (2010) Cancer , vol.116 , pp. 2166
    • Singhi, A.D.1    Westra, W.H.2
  • 27
    • 33947140297 scopus 로고    scopus 로고
    • Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer
    • Reimers N, Kasper HU, Weissenborn SJ, et al. Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer. Int J Cancer 2007;120: 1731.
    • (2007) Int J Cancer , vol.120 , pp. 1731
    • Reimers, N.1    Kasper, H.U.2    Weissenborn, S.J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.